The Centre National de Génotypage (CNG) was established in 1997 by the Ministry of Research and Innovation and in 2007 became part of the Commissariat à l'Energie Atomique (CEA).
The mission of the CNG is to develop and to apply genomic, bioinformatics and statistical methods, principally in order to identify, characterise and translate into clinics the genetic basis of human disease.
Group : Genomics and Pathophysiology of Cardiovascular Diseases
The Genomics and Pathophysiology of Cardiovascular Diseases group of the UMR_S-1166 focuses its research on :
The Centre d'Etude du Polymorphisme Humain (CEPH) was established in 1984 by Jean Dausset, Nobel Prize for Medecine in 1980, to promote an international collaborative research effort to map the human genome, the first step in developing individualized genomic medicine.
This successful model of international collaboration has been used to organize the "Human Genome Diversity Panel – CEPH, a program used to study genetic diversity in humans.